Alkermes Plc (ALKS)
36.80
-0.15
(-0.41%)
USD |
NASDAQ |
May 22, 16:00
36.55
-0.25
(-0.68%)
After-Hours: 20:00
Alkermes Free Cash Flow : 221.80M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amarin Corp. Plc | 25.63M |
| Xenon Pharmaceuticals, Inc. | -307.84M |
| Tyra Biosciences, Inc. | -102.47M |
| Spyre Therapeutics, Inc. | -185.87M |
| Agios Pharmaceuticals, Inc. | -384.73M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -165.74M |
| Cash from Investing (Quarterly) | -2.077B |
| Cash from Financing (Quarterly) | 1.475B |
| Free Cash Flow Per Share (Quarterly) | -1.022 |
| Free Cash Flow to Equity (Quarterly) | -1.681B |
| Free Cash Flow to Firm (Quarterly) | -147.40M |
| Free Cash Flow Yield | 3.58% |